Imran Satia
McMaster University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Imran Satia as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:28 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07288528 · A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic CoughMcMaster University · not yet recruiting · Cough, Refractory Chronic Cough, Unexplained Chronic Cough · principal investigator
- N/ANCT06600646 · Investigating the Role of ATP Production by Airway Epithelium in Patients With Refractory and Unexplained Chronic Cough (RCC/UCC).McMaster University · recruiting · Chronic Cough (CC) · principal investigator
- Ph4NCT04765722 · Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways DiseasesMcMaster University · completed · Chronic Cough, Eosinophilic Bronchitis, Asthma · principal investigator
- N/ANCT04758351 · Prospective Study on the Evaluation, Patient Reported Outcomes and Effectiveness of Treatment for Chronic CoughMcMaster University · completed · Chronic Cough · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:28 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- 80 citationsRCR 5.1
- Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma.J Allergy Clin Immunol · 201954 citationsRCR 2.9
- Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough .Int J Clin Pharmacol Ther · 201734 citationsRCR 1.8
- 32 citationsRCR 1.5
- Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial.Eur Respir J · 202423 citationsRCR 3.7
- A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough.J Allergy Clin Immunol Pract · 202122 citationsRCR 1.9
- Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial.Nat Commun · 202518 citationsRCR 4.0
- Limosilactobacillus reuteri DSM-17938 for preventing cough in adults with mild allergic asthma: A double-blind randomized placebo-controlled cross-over study.Clin Exp Allergy · 202111 citationsRCR 0.8
- 9 citationsRCR 1.0
- 7 citationsRCR 3.5